Dates: 14 February, 07 March, 04 April, 02 May, 30 May, 27 June, 25 July, 22 August, 19 September, 17 October, 14 November, 12 December
Documentation to be considered at a meeting needs to be received one week prior to the meeting date.
Covid -19 Infection in Pregnancy Registry
This national registry was established in 2020 and aims to include all women who have a positive COVID-19 test or who have confirmed or probable COVID-19 disease during pregnancy or within 6 weeks after birth. Women will be included in the registry whether or not they develop symptoms, and it will include women who have an early pregnancy loss. Women who have had COVID-19 and have now completed their pregnancies will also be included.
What are we asking you to do?
GPs, midwives, obstetricians in primary care or hospital clinicians are asked to notify us of all women under their care with confirmed or suspected COVID‐19:
With or without symptoms
At any time in pregnancy or within 6 weeks postpartum (including early pregnancy loss)
Informing women – Women must be advised if their details are forwarded to the COVID‐19 Registry, and provided with an information sheet (attached), available from www.liggins.auckland.ac.nz/covid19(). Women may self‐report using the Registry website if they wish to do so. Women may elect to opt off the Registry Database by notifying Registry staff at firstname.lastname@example.org or 021 0831 4824.
Approval. This Registry has been reviewed and received ethical approval from the Health and Disability Ethics Committee, reference (20/NTB/81). The Registry has the support of the Ministry of Health, Te Kāhui Oranga ō Nuku, RANZCOG, NZCOM, the Paediatric Society of NZ, NZ Newborn Network, NZ Paediatric Surveillance Unit, National Maternity Monitoring Group, Royal NZ College of GPs.
Rebecca Hay (Research midwife), Laura Mackay (Research Co-ordinator)
Associate Professor Katie Groom, maternal fetal medicine subspecialist, University of Auckland, Auckland DHB * Dr Lynn Sadler, perinatal epidemiologist, University of Auckland, Auckland DHB * Associate Professor Nicola Austin, neonatologist, Canterbury DHB, Dr Kasey Tawhara, obstetrics & gynaecology registrar, Lakes DHB. Ngāti Raukawa, Ngāti Porou
Can we safely reduce the risk of breathing problems for newborn babies by giving corticosteroid injections to their mothers before a planned caesarean section?
This trial is underway at Auckland Hospital and Liggins Institute, The University of Auckland. This trial may be suitable for you if you are having a planned caesarean section at 35 – 39+6 weeks of pregnancy. Find our more at the C*STEROID Trial website www.liggins.auckland.ac.nz/csteroid() or contact the team at email@example.com
The GEMS Study is examining the best criteria for testing for diabetes during pregnancy. This study has now completed recruitment. For more information, visit the GEMS study website.()
The FIIX Study is a clinical trial comparing the two main fertility procedures available through public funding in New Zealand – The Fertility and InVitro Fertilisation (IVF) and Intra Uterine Insemination (IUI) trial in couples with uneXplained infertility.
Couples with unexplained infertility who have been accepted for publicly funded fertility treatment are suitable to participate.